BSE filing, NSE: ESSENTIA. Summary written from the filing by ALFA Finder's alert engine.
Integra Essentia Ltd: key numbers
- Share price
- ₹0.91
- Market cap
- ₹159.7 Cr
- Revenue (annual)
- ₹473.6 Cr
- Net profit (annual)
- ₹0.32 Cr
- P/E (TTM)
- -875.0×Sector 50.0×
- Promoter holding
- 9.72%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Integra Essentia Ltd
All →Integra Essentia Q2 FY27 Results: Net Profit ₹0 Cr
Integra Essentia Ltd reported revenue from operations of ₹142 Cr (+17.6% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Integra Essentia Board Meeting Date
Integra Essentia will hold a board meeting on October 31, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window remains closed until 48 hours after results are declared.
Integra Essentia Other Announcement
Integra Essentia Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Integra Essentia Annual General Meeting
Integra Essentia held its 19th Annual General Meeting on September 28, 2026. The meeting covered financial statement adoption, director reappointments, and related party transactions.
Integra Essentia Annual General Meeting
Integra Essentia Ltd will convene its 19th Annual General Meeting on September 28, 2026. The company has approved the book closure dates for this purpose.
Integra Essentia Q1 FY27 Results: Net Profit ₹0 Cr
Integra Essentia Ltd reported revenue from operations of ₹111.9 Cr (+42.2% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.